Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism α4β2 receptor modulators(α4β2 receptor modulators), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H18FN3 |
InChIKeyJGOKWXDQJRLPLM-SQZVAGKESA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Phase 1 | US | 18 Aug 2022 |